Viewed: 293
Emailed: 0
PDF Downloaded: 395
Full Text PDF Share on Facebook Share on Twitter
Original Article
Author Details :
Volume : 12, Issue : 2, Year : 2022
Article Page : 223-226
https://10.18231/j.pjms.2022.042
Abstract
Background: With the rising mortality rate, worldwide liver cirrhosis has been ranked as the 13th leading cause of mortality. Portal hypertension is one of the common consequences of liver cirrhosis. Further, portal hypertension has its own complications and the most serious among them is the risk of development of esophageal varices (EV) caused by increased hepatic vascular resistance related to hepatic fibrosis and regenerative nodules.
Aim: To identify the non-endoscopic predictor of esophageal varices in patients with liver cirrhosis in a tertiary care hospital
Materials and Methods: A prospective study was carried out at the tertiary care hospital of Dr. PDMMC, Amravati between the period September 2018 to March 2020. One hundred patients diagnosed with liver cirrhosis were taken for the study. The patients were selected based on the clinical, the radiological and historical data.
Results: The patients were divided into two groups, namely the small size of varices group where n=71 and large size of varices group where n=29. Factors such as platelet count, serum albumin, spleen (cm), PV (mm), platelet count and child-pugh classification were considered important as their p values were less than 0.05.
Conclusion: The platelet count and the spleen size showed the difference among the patients belonging to small varices and larger varices group, respectively. Ascites was noted in 90% of the cases. 65% of the patients suffered from portal gastropathy and esophageal varices.
Keywords: Esophageal varices, Liver cirrhosis
How to cite : Daphale A, Jagtap P, Non endoscopic predictor of esophageal varices in patients with cirrhosis of liver from tertiary care hospital. Panacea J Med Sci 2022;12(2):223-226
Copyright © 2022 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)